HDAC9 and non-small cell lung carcinoma: We previously combined a HDAC inhibitor (vorinostat) and a demethylating agent and noted the initiation of expression of a number of tumor suppressor genes in a variety of tumors including NSCLC, endometrial, prostate, ovary and pancreatic cancers [15, 18–22].